EUVIMEDEUVIMED entdecken
Übersichtsarbeit

PET/Computed Tomography Transformation of Oncology

Alireza Ghodsi, Rodney J Hicks, Amir Iravani

PET Clinics · 2024

DOI: 10.1016/j.cpet.2023.12.012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PET Clinics, 2024. Verfasst von Alireza Ghodsi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Washington, 1144 Eastlake Avenue East, Seattle, WA 98109, USA. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy approaches have changed the treatment landscape in a variety of malignancies with a high anti-tumor response. Immunotherapy may be associated with novel response and progression patterns that pose a substantial challenge to the conventional criteria for assessing treatment response, including response evaluation criteria in solid tumors (RECIST) 1.1. In addition to the morphologic details provided by computed tomography (CT) and MRI, hybrid molecular imaging emerges as a comprehensive imaging modality with the capacity to interrogate pathophysiological mechanisms like glucose metabolism. This review highlights the current status of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) in prognostication, response monitoring, and identifying immune-related adverse events. Furthermore, it investigates the potential role of novel immuno-PET tracers that could complement the utilization of 18F-FDG PET/CT by imaging the specific pathways involved in immunotherapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18NeoplasmsHumansPositron Emission Tomography Computed TomographyRadiopharmaceuticalsTomography, X-Ray ComputedPositron-Emission TomographyImmunotherapy

Stichwörter der Autor:innen

(18)F-FDG PET/CTImmune responseImmunotherapyMolecular imagingRadiopharmaceuticals

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Radiology, University of Washington, 1144 Eastlake Avenue East, Seattle, WA 98109, USA.
  • Department of Medicine, St Vincent's Hospital, The University of Melbourne, Australia; Department of Medicine, Central Clinical School, The Alfred Hospital, Monash University, Melbourne, Australia; The Melbourne Therano…
  • Department of Radiology, University of Washington, 1144 Eastlake Avenue East, Seattle, WA 98109, USA. Electronic address: airavani@uw.edu.

Zitieren

APA

Ghodsi, A., Hicks, R. J., & Iravani, A. (2024). PET/Computed Tomography Transformation of Oncology. PET Clinics. https://doi.org/10.1016/j.cpet.2023.12.012

Vancouver

Ghodsi A, Hicks RJ, Iravani A. PET/Computed Tomography Transformation of Oncology. PET Clinics. 2024. doi:10.1016/j.cpet.2023.12.012

BibTeX
@article{Ghodsi2024,
  author = {Ghodsi, Alireza and Hicks, Rodney J and Iravani, Amir},
  title = {PET/Computed Tomography Transformation of Oncology},
  journal = {PET Clinics},
  year = {2024},
  doi = {10.1016/j.cpet.2023.12.012}
}
Kostenlos starten →